These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 25253560)
21. Doxorubicin has in vivo toxicological effects on ex vivo cultured mesenchymal stem cells. Oliveira MS; Carvalho JL; Campos AC; Gomes DA; de Goes AM; Melo MM Toxicol Lett; 2014 Jan; 224(3):380-6. PubMed ID: 24291741 [TBL] [Abstract][Full Text] [Related]
23. Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress. Li W; Xu B; Xu J; Wu XL Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):192-7. PubMed ID: 19143757 [TBL] [Abstract][Full Text] [Related]
24. The protective role of p72 in doxorubicin‑induced cardiomyocytes injury in vitro. Lin B; Wang F; Wang J; Xu C; Zhao H; Cheng Z; Feng D Mol Med Rep; 2016 Oct; 14(4):3376-80. PubMed ID: 27510756 [TBL] [Abstract][Full Text] [Related]
25. Adipocytokine, omentin inhibits doxorubicin-induced H9c2 cardiomyoblasts apoptosis through the inhibition of mitochondrial reactive oxygen species. Kazama K; Okada M; Yamawaki H Biochem Biophys Res Commun; 2015 Feb; 457(4):602-7. PubMed ID: 25600813 [TBL] [Abstract][Full Text] [Related]
26. The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice. Bruynzeel AM; Mul PP; Berkhof J; Bast A; Niessen HW; van der Vijgh WJ Cancer Chemother Pharmacol; 2006 Nov; 58(5):699-702. PubMed ID: 16565833 [TBL] [Abstract][Full Text] [Related]
27. Neuregulin-1 attenuates doxorubicin-induced autophagy in neonatal rat cardiomyocytes. An T; Huang Y; Zhou Q; Wei BQ; Zhang RC; Yin SJ; Zou CH; Zhang YH; Zhang J J Cardiovasc Pharmacol; 2013 Aug; 62(2):130-7. PubMed ID: 23519142 [TBL] [Abstract][Full Text] [Related]
28. Oxidative stress on cardiotoxicity after treatment with single and multiple doses of doxorubicin. Segredo MP; Salvadori DM; Rocha NS; Moretto FC; Correa CR; Camargo EA; de Almeida DC; Reis RA; Freire CM; Braz MG; Tang G; Matsubara LS; Matsubara BB; Yeum KJ; Ferreira AL Hum Exp Toxicol; 2014 Jul; 33(7):748-60. PubMed ID: 24275640 [TBL] [Abstract][Full Text] [Related]
29. Redox-proteomic analysis of doxorubicin-induced altered thiol activity in cardiomyocytes. Lin ST; Chou HC; Chen YW; Chan HL Mol Biosyst; 2013 Mar; 9(3):447-56. PubMed ID: 23340498 [TBL] [Abstract][Full Text] [Related]
30. Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes. Asensio-Lopez MC; Sanchez-Mas J; Pascual-Figal DA; de Torre C; Valdes M; Lax A Free Radic Biol Med; 2014 Feb; 67():19-29. PubMed ID: 24231192 [TBL] [Abstract][Full Text] [Related]
31. A major green tea component, (-)-epigallocatechin-3-gallate, ameliorates doxorubicin-mediated cardiotoxicity in cardiomyocytes of neonatal rats. Li W; Nie S; Xie M; Chen Y; Li C; Zhang H J Agric Food Chem; 2010 Aug; 58(16):8977-82. PubMed ID: 20666448 [TBL] [Abstract][Full Text] [Related]
32. Tanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis. Gao J; Yang G; Pi R; Li R; Wang P; Zhang H; Le K; Chen S; Liu P Transl Res; 2008 Feb; 151(2):79-87. PubMed ID: 18201675 [TBL] [Abstract][Full Text] [Related]
33. The iron chelator Dp44mT does not protect myocytes against doxorubicin. Hasinoff BB; Patel D J Inorg Biochem; 2009 Jul; 103(7):1093-101. PubMed ID: 19535146 [TBL] [Abstract][Full Text] [Related]
34. [The in vitro cytotoxicity and in vivo toxicity of doxorubicin antiresistant stealth liposomes]. Wang JC; Liu XY; Lü WL; Lee HS; Goh BC; Zhang Q Yao Xue Xue Bao; 2005 May; 40(5):475-80. PubMed ID: 16220797 [TBL] [Abstract][Full Text] [Related]
35. Regulation of kinase cascade activation and heat shock protein expression by poly(ADP-ribose) polymerase inhibition in doxorubicin-induced heart failure. Bartha E; Solti I; Szabo A; Olah G; Magyar K; Szabados E; Kalai T; Hideg K; Toth K; Gero D; Szabo C; Sumegi B; Halmosi R J Cardiovasc Pharmacol; 2011 Oct; 58(4):380-91. PubMed ID: 21697725 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of chymotryptic-like standard proteasome activity exacerbates doxorubicin-induced cytotoxicity in primary cardiomyocytes. Spur EM; Althof N; Respondek D; Klingel K; Heuser A; Overkleeft HS; Voigt A Toxicology; 2016 Apr; 353-354():34-47. PubMed ID: 27155237 [TBL] [Abstract][Full Text] [Related]
37. Embryonic stem cell-derived cardiomyocytes as a model system to study cardioprotective effects of dexamethasone in doxorubicin cardiotoxicity. Farokhpour M; Karbalaie K; Tanhaei S; Nematollahi M; Etebari M; Sadeghi HM; Nasr-Esfahani MH; Baharvand H Toxicol In Vitro; 2009 Oct; 23(7):1422-8. PubMed ID: 19596060 [TBL] [Abstract][Full Text] [Related]
38. Doxorubicin-induced reactive oxygen species generation and intracellular Ca2+ increase are reciprocally modulated in rat cardiomyocytes. Kim SY; Kim SJ; Kim BJ; Rah SY; Chung SM; Im MJ; Kim UH Exp Mol Med; 2006 Oct; 38(5):535-45. PubMed ID: 17079870 [TBL] [Abstract][Full Text] [Related]